Professor Seppo Ylä-Herttuala receives the 2023 ESGCT Outstanding Achievement Award
The European Society of Gene and Cell Therapy (ESGCT) has selected our Flagship’s director, Professor Seppo Ylä-Herttuala, as the winner of the 2023 ESGCT Outstanding Achievement Award in recognition of his long and successful career in the field of gene therapy research.
The Outstanding Achievement Award was presented on 25 October in the ESGCT Annual Congress held in Brussels. In his acceptance speech, Professor Ylä-Herttuala emphasized that gene therapy research requires time and patience and the foresight to consider requirements for clinical trials already during preclinical research.
Read more:
https://www.esgct.eu/post/seppo-yla-herttuala-winner-of-2023-outstanding-achievement-award